Serving New York veterinarians since 1890  |  Pet Owners: Get Help

New York State Veterinary Medical Society

What can we learn by eavesdropping on immune cells?
Cornell University CVM

The immune system is a highly complex biological process that involves many different and highly specialized cells. Understanding how all these pieces work together matters – a lot – because immune responses are something doctors would like to be able to control better.

continue reading

 


Incorporating contextualized care strategies into practice workflows
AVMA

As veterinarians report decreasing visits amid increasing price sensitivity among pet owners, reducing barriers to veterinary care remains a key priority for the profession. And while cost remains the dominant obstacle, logistical factors such as appointment availability and transportation also play a role.

continue reading

 


Federal judge dismisses antitrust lawsuit against AVMA
AVMA

The AVMA has prevailed in a lawsuit that Lincoln Memorial University (LMU) filed last June on behalf of its two veterinary colleges. The private university claimed that its Richard A. Gillespie College of Veterinary Medicine in Harrogate, Tennessee (LMU-TN), was harmed by being placed on probationary accreditation by the AVMA Council on Education (AVMA COE).

continue reading

 


AAHA releases canine-focused diabetes guidelines
AVMA

The American Animal Hospital Association’s (AAHA’s) first canine-focused diabetes guidelines reflect advances in canine diabetes care and recommend how to incorporate new treatments into therapeutic approaches. The 2026 AAHA Diabetes Management Guidelines for Dogs builds on clinically relevant information from the 2018 AAHA Diabetes Management Guidelines while presenting new findings and expert opinion.

continue reading

 


Experimental drug found to slow bone cancer cell growth in dog and human lab tests

DVM360

An experimental cancer drug was found to slow the growth of canine and human osteosarcoma cells in laboratory tests conducted at The Ohio State University College of Veterinary Medicine, according to findings announced by the drug’s developer, Telomir Pharmaceuticals. The drug, Telomir-Zn, was tested on cancer cells grown in-vitro—in a lab rather than in animals or people.

continue reading

 


Understanding autumn laminitis in horses

The Horse

Laminitis in horses can strike any time of year, for a variety of reasons, but veterinarians and horse owners see endocrinopathic cases most commonly in spring and autumn. Understanding your horse’s risk level for this painful and potentially deadly hoof condition—and the physiological differences between spring and autumn laminitis—is critical to prevention.

continue reading